why choose us

First received: June 02, 2023

Clinical Trial: Sucralose and Lactisole Additions to OGTT in Humans

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Neat OGTT

Study Type: INTERVENTIONAL


Official Title: Activation and Inhibition of the Sweet Taste Receptor T1R2-T1R3 Differentially Affect Glucose Tolerance in Humans

Brief Summary: In the present study, our objective was to determine whether T1R2-T1R3 influences glucose metabolism bidirectionally via hyperactivation with sucralose and inhibition with sodium lactisole in mixture with glucose loads during tolerance tests in humans.In 12 healthy participants we conducted oral glucose tolerance tests (OGTTs) of 75 g glucose with and without the addition of the T1R2-T1R3 agonist, sucralose (5 mM).We also conducted OGTTs in 10 healthy participants with and without the addition of a T1R2-T1R3…

Read more